Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
-
- SHIMASAKI Takeo
- Department of Medical Oncology, Kanazawa Medical University
-
- ISHIGAKI Yasuhito
- Medical Research Institute, Kanazawa Medical University
-
- NAKAMURA Yuka
- Medical Research Institute, Kanazawa Medical University
-
- TAKATA Takanobu
- Medical Research Institute, Kanazawa Medical University
-
- NAKAYA Naoki
- Department of Medical Oncology, Kanazawa Medical University
-
- NAKAJIMA Hideo
- Department of Medical Oncology, Kanazawa Medical University
-
- SATO Itaru
- Department of Medical Oncology, Kanazawa Medical University
-
- ZHAO Xia
- Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
-
- KITANO Ayako
- Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University
-
- KAWAKAMI Kazuyuki
- Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University
-
- TANAKA Takuji
- Department of Pathology, Kanazawa Medical University
-
- TAKEGAMI Tsutomu
- Medical Research Institute, Kanazawa Medical University
-
- TOMOSUGI Naohisa
- Medical Research Institute, Kanazawa Medical University
-
- MINAMOTO Toshinari
- Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University
-
- MOTOO Yoshiharu
- Department of Medical Oncology, Kanazawa Medical University
この論文をさがす
収録刊行物
-
- Journal of gastroenterology
-
Journal of gastroenterology 47 (3), 321-333, 2012-03-01
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1573387450553150976
-
- NII論文ID
- 10030560208
-
- NII書誌ID
- AA10988015
-
- ISSN
- 09441174
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles